Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03361358 · ClinicalTrials.gov registry record
Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
A clinical trial, sponsored by Agios Pharmaceuticals.
- Completed
- Registry status
- 44
- Enrollment target
NCT03361358 is a clinical trial that has completed, run by Agios Pharmaceuticals. The registered enrollment target is 44 participants.
The verdict
NCT03361358 has completed, sponsored by Agios Pharmaceuticals.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to identify subjects with advanced solid tumors or lymphoma in which the methylthioadenosine phosphorylase (MTAP) protein has been lost.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03361358
The ClinicalTrials.gov registry entry for NCT03361358 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agios Pharmaceuticals, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03361358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03361358 about?
NCT03361358 is a clinical study titled "Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma". The purpose of this study is to identify subjects with advanced solid tumors or lymphoma in which the methylthioadenosine phosphorylase (MTAP) protein has been lost.
What is the current status of trial NCT03361358?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2018-03-01. Estimated completion is 2019-09-30.
Who is sponsoring clinical trial NCT03361358?
This trial is sponsored by Agios Pharmaceuticals, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.